Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
- PMID: 9673301
- DOI: 10.1056/NEJM199807233390404
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
Abstract
Background: Type 2 (non-insulin-dependent) diabetes is associated with a marked increase in the risk of coronary heart disease. It has been debated whether patients with diabetes who have not had myocardial infarctions should be treated as aggressively for cardiovascular risk factors as patients who have had myocardial infarctions.
Methods: To address this issue, we compared the seven-year incidence of myocardial infarction (fatal and nonfatal) among 1373 nondiabetic subjects with the incidence among 1059 diabetic subjects, all from a Finnish population-based study.
Results: The seven-year incidence rates of myocardial infarction in nondiabetic subjects with and without prior myocardial infarction at base line were 18.8 percent and 3.5 percent, respectively (P<0.001). The seven-year incidence rates of myocardial infarction in diabetic subjects with and without prior myocardial infarction at base line were 45.0 percent and 20.2 percent, respectively (P<0.001). The hazard ratio for death from coronary heart disease for diabetic subjects without prior myocardial infarction as compared with nondiabetic subjects with prior myocardial infarction was not significantly different from 1.0 (hazard ratio, 1.4; 95 percent confidence interval, 0.7 to 2.6) after adjustment for age and sex, suggesting similar risks of infarction in the two groups. After further adjustment for total cholesterol, hypertension, and smoking, this hazard ratio remained close to 1.0 (hazard ratio, 1.2; 95 percent confidence interval, 0.6 to 2.4).
Conclusions: Our data suggest that diabetic patients without previous myocardial infarction have as high a risk of myocardial infarction as nondiabetic patients with previous myocardial infarction. These data provide a rationale for treating cardiovascular risk factors in diabetic patients as aggressively as in nondiabetic patients with prior myocardial infarction.
Comment in
-
Diabetes and coronary heart disease.N Engl J Med. 1998 Dec 3;339(23):1714-5; author reply 1716. doi: 10.1056/NEJM199812033392314. N Engl J Med. 1998. PMID: 9867543 No abstract available.
-
Diabetes and coronary heart disease.N Engl J Med. 1998 Dec 3;339(23):1715; author reply 1716. N Engl J Med. 1998. PMID: 9867544 No abstract available.
-
Diabetes and coronary heart disease.N Engl J Med. 1998 Dec 3;339(23):1715; author reply 1716. N Engl J Med. 1998. PMID: 9867545 No abstract available.
-
Diabetes and coronary heart disease.N Engl J Med. 1998 Dec 3;339(23):1715-6. N Engl J Med. 1998. PMID: 9867546 No abstract available.
Similar articles
-
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.Circulation. 2008 Apr 15;117(15):1945-54. doi: 10.1161/CIRCULATIONAHA.107.720847. Epub 2008 Mar 31. Circulation. 2008. PMID: 18378618
-
The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators.N Engl J Med. 2000 Apr 6;342(14):989-97. doi: 10.1056/NEJM200004063421401. N Engl J Med. 2000. PMID: 10749960
-
Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.Ann Thorac Surg. 2008 Oct;86(4):1181-8. doi: 10.1016/j.athoracsur.2008.06.063. Ann Thorac Surg. 2008. PMID: 18805157
-
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.Arthritis Rheum. 2005 Feb;52(2):402-11. doi: 10.1002/art.20853. Arthritis Rheum. 2005. PMID: 15693010 Review.
-
Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature.Arch Cardiovasc Dis. 2011 Mar;104(3):178-88. doi: 10.1016/j.acvd.2010.11.013. Epub 2011 Mar 26. Arch Cardiovasc Dis. 2011. PMID: 21497307 Review.
Cited by
-
Update on type 2 diabetes as a cardiovascular disease risk equivalent.Curr Cardiol Rep. 2013 Feb;15(2):331. doi: 10.1007/s11886-012-0331-5. Curr Cardiol Rep. 2013. PMID: 23299711 Review.
-
Telomeres and atherosclerosis.Cardiovasc J Afr. 2012 Nov;23(10):563-71. doi: 10.5830/CVJA-2012-056. Cardiovasc J Afr. 2012. PMID: 23192261 Free PMC article. Review.
-
Managing the multifaceted nature of type 2 diabetes using once-weekly injectable GLP-1 receptor agonist therapy.J Clin Pharm Ther. 2020 Sep;45 Suppl 1(Suppl 1):7-16. doi: 10.1111/jcpt.13229. J Clin Pharm Ther. 2020. PMID: 32910488 Free PMC article. Review.
-
Aldose reductase, oxidative stress, and diabetic mellitus.Front Pharmacol. 2012 May 9;3:87. doi: 10.3389/fphar.2012.00087. eCollection 2012. Front Pharmacol. 2012. PMID: 22582044 Free PMC article.
-
The effect of almonds on inflammation and oxidative stress in Chinese patients with type 2 diabetes mellitus: a randomized crossover controlled feeding trial.Eur J Nutr. 2013 Apr;52(3):927-35. doi: 10.1007/s00394-012-0400-y. Epub 2012 Jun 22. Eur J Nutr. 2013. PMID: 22722891 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical